Prolonged hyperventilation is required for release of tumor necrosis factor a but not IL-6

Applied Cardiopulmonary Pathophysiology

Volumn 6, Issue 3, 1996, Pages 171-177

  Von Bethmann, Alexander N ^a,b,c   Brasch, Frank ^a   Muller K ^a   Wendel, A ^a   Uhlig, S ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BAROTRAUMA; LUNG ALVEOLUS WALL; LUNG EDEMA; LUNG INJURY; MECHANICAL STRESS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TIME;

EID: 0030425482     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aldrich, TK, Prezant DJ. Indications for mechanical ventilation. In: Tobin MJ (ed) Principles and Practice of Mechanical Ventilation. New York: McGraw-Hill, 1994: 155-89.
2. Haake R, Schlichtig R, Uistad DR, Menschen RR. Barotrauma. Pathophysiology, risk factors and prevention. Chest 1987; 91: 608-12.
3. Ulich RU. Tumor Necrosis Factor. In: Kelley J (ed) Cytokines of the Lung. New York: Marcel Dckkcr Inc, 1993: 307-32.
4. Wheeler AP, Hardie WD, Bernard GR. The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep. Am. Rev. Respir. Dis. 1992; 145: 632-39.
5. Kreill, EA, Greene E, Fitzgibbon C, Robinson DR, Zapol WM. Effects of recombinant tumor necrosis factor alpha, lymphotoxin, and Eschericia Coli lipopolysaccharide on hemodynamics, lung microvascular permeability, and eicosanoid synthesis in anaesthetised sheep. Circ. Res. 1989; 65: 502-14.
6. Huang YC, Fracica PJ, Piantadosi CA. Tumor necrosis factoralpha-induced lung injury and its modulation by synthetic polynuclcotide: a physiologic-morphometric analysis. Exp. Lung Res. 1994; 20: 539-58.
7. Sorkine P. Setton A, Halpcrn P. Miller A. Rudick V. Marmor S et al. Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration. Crit. Care Med. 1995; 23: 1377-81.
8. Collctti. LM. Remick DO, Burtch GD, Kunkel SL, Stricter RM, Campbcll DA. Role of tumor necrosis factor-alpha in the pathophysiological alterations after ischemia/reperfusion injury in the rat. J. Clin. Invest. 1990; 85: 1936-43.
9. Palace GP. Vecchio PJ. Morgan. MJ. Malik AB. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am. Rev. Respir. Dis. 1993: 147: 143-7.
10. Suter PM. Suter S. Girardin E, Roux-Lombard P, Grau DE. Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, inlerleukin 1, interfcron. and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am. Rev. Respir. Dis. 1992: 145: 1016-22.
11. Meduri GU. Kohler G, Headley S, Tollcy E. Stem/ F, Postlethwailc A. Inflammatory cytokines in the BAI. of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995: IDS: 131)3-14.
12. Meduri GU. Headley S, Kohler G. Stentz F. Tollcy E. Umberger R, Keeper K. Inflammatory cytokines in the BAL of patients with ARDS. Plasma IL-lb and IL-6 levels are consistent and efficient predictors of outcome. Chest 1995; 107: 1062-73.
13. Zitnik RJ. Elias JA. lnterleukin-6 and the Lung. In: Kelley J (cd) Cylokines of the Lung. New York: Marcel Dekker Inc. 1993: 229-80.
14. Hankey PE. Williams JG, Guice KS. Taylor SN. Inlerleukin-6 production after thermal injury: evidence for nonmacrophage sources in the lung and liver. Surgery 1995; 118: 431-8.
15. Thievierge M. Rola-Pleszczynski M. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J. Allergy Clin. Immunol. 1992: 90: 796-802.
16. Rolfe MW. Kunkel SL, Rowcns B, Standiford TJ. Cragoe EJ Jr. Stricter RM. Suppression of human alveolar macrophagederived cytokines by amiloride. Am. J. Respir. C'ell Mol. Biol. 1992: 6: 576-82.
17. Fahisiak JP. Weiss RD. Powell GA. Dauber JH. Enhanced secretion of immune-modulating cytokines by human lung fibrohlasts during in vitro infection with Mycoplasma fermentans. Am. .1. Respir. Cell Mol. Biol. 1993; 8: 358-64.
18. Monick MM. Aksamit TR, Geist LJ, Hunninghake GW. Dcxamcthasone inibits IL I and TNF activity in human lung fibrob lasts without affecting IL-I or TNF receptors. Am. J. Physiol. 1994; 267: L33-8.
19. Fries KM, Felch ME. Phipps RP. lnterleukin-6 is an automne growth factor for murine lung libroblast subsets. Am. J. Respir. Cell Mol. Biol. 1994; 11:552-60.
20. Banchereau J. Converging and diverging properties of human interleukin-4 and imerleukin-IO. Behring Inst. Mitt. 1995: Jim (96): 58-77.
21. Mulligan MS. Jones ML. Vaporeiyan AA, Howard MC. Ward. PA. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 1993: 151: 5666-74.
22. von Bcthmann A. Brasch F. Müller K-M, Uhlig S. Barotrauma induced cytokine- and eicosanoid-relcase from the isolated and perfused mouse lung. Am. J. Respir. Crit. Care Med. 1996; 153: A529.
23. Barsig J. Küsters S. Vogt K, Volk H-D. Tiegs G, Wendel A. Lipopolysaccharide-induccd interleukin-10 in mice: role of endogenous tumor necrosis t'actor-a. Eur. J. Immunol. 1995: 25: 2888-93.
24. Uhlig, S. Brasch F, Wollin L. Fchrcnhach H. Richter J, Wendel A. Functional and tine slruetural changes in isolated rat lungs challenged wilh endotoxin cx vivo and in vitro. Am. j. Pathol. 1995: 146: 1235-17.
25. Felix JA, Woodruff ML. Dirksen ER. Stretch increases inositol 1.4,5-lrisphosphate concentration in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 1996: 14: 296-301.
26. Lansman JB. Hallam TJ, Rink TJ. Single stretch-activated ion channels in vascular endolhelial cells as mechanotransducers ? Nature 1987: 325: XI1-3.
27. Martin DK. Bootcov MR. Campbell TJ. French PW. Breit SN. Human macrophages contain a stretch-sensitive potassium channel that is activated by adherence and cytokines. J. Membrane Biol. 1995: 147: 305-15.
28. Beutler. B. Cachectin (Tumor necrosis factor) and lymphotoxin. ISI Atlas of Science: Immunology 1988; 101-5.
29. Gearing AJH. Beckell P. Christodoulou M. Churchill M. Clements JM. Crimmin M et al. Matrix metalloproteinases and processing of pro-TNFa. J Leukocyte Biol. 1995: 57: 774-7.
30. Crestani B, Cornillet P. Dehoux M. Rolland C, Guenounou M. Aubier M. Alveolar type II epithelial cells produce interleukin6 in vitro and in vivo. Regulation by alveolar macrophage products. J. Clin. Invest. 1994; 731-40.
31. Dentener MA, Bazil V. von Asmuth HJ. Ceska M. Bumman WA. Involvement of CD 14 in lipopolysaccharide-indnced tumor necrosis factor-alpha, IL-6 and II.-8 release by human monocytes and alveolar macrophages. J. Immunol. 1993: 150: 2885-91.
32. Persoons. JFfA, Schornagel K. Breve J. Berkenbosch F. Kraal G. Acute stress affects cytokines and nitric oxide production differently. Am. J. Respir. Crit. Care Med. 1995: 152: 619-24.
33. Imai Y. Kawano T. Miyasaka K, Takata M. Imai T, Okuyama K. Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am. J. Respir. Crit. Care Med. 1994; 150: 1550-4.
34. Takata M, Abe J, Tanaka II, Kitano Y. Doi S. Kohsaka T. Miyasaka K. Inlra-alveolar expression of tumor necrosis factoralpha gene during conventional and high frequency ventilation. Am. J. Respir. Crit. Care Med. 1996; 153: A392.
35. Narimanbekov IO. Ro/ycki HJ. Hffecl of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. Exp. Lung Res. 1995: 21: 239-54.
36. Berg JT. Fu 7,. Breen EC, Tran H-C. Mathieu-Costello (X West JB. High lung inflation increases gene expression of extracellular matrix components in lung parenchyma. Am. J. Respir. C'rit. Care Med. 1996; 153: A393.
37. Guclu G. Nakamura T. Tremblay L, Volgyezi G. Downev (iP, Slutsky AS. Mechanical ventilation of normal lung with high tidal volume and PEEP induces priming of circulating neutrophils. Am. J. Respir. C'rit. Care Med. I99(,: 153: A3'/3.